Vexasyn by Sterling-Knight Pharmaceuticals, LLC VEXASYN-

Vexasyn by

Drug Labeling and Warnings

Vexasyn by is a Prescription medication manufactured, distributed, or labeled by Sterling-Knight Pharmaceuticals, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Vexasyn is a soothing wound gel that promotes a moist wound environment that is ideal for the healing process.

Directions:

Cleanse wound then apply Vexasyn to the wound and skin surrounding the wound 3 - 4 times daily.

Indications:

For the local management of painful skin wounds, including:
Pressure ulcers
Venus stasis ulcers
Superficial wounds and scrapes
1st and 2nd degree burns

Warnings:

External use only. Do not use this product if you are allergic to any of the ingredients. Avoid contact with eyes. Sterile unless opened or damaged.

Caution:

Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner.

Storage:

Store at 25°C (77°F): excursions permitted to 15°-30°C (59°-86°F). Protect from freezing [See USP Controlled Room Temperature].

Ingredients:

Ingredients: Water, Lidocaine HCl, Collagen, Aloe Vera gel, Sodium alginate, Glycerin, Hydroxyethylcellulose, Triethanolamine, Benzethonium chloride.

SPL UNCLASSIFIED SECTION

CALL YOUR DOCTOR ABOUT SIDE EFFECTS.
Call your doctor about side effects. You may report side effects to Sterling Knight Pharmaceuticals, LLC at 1-888-460-1531 or the FDA at 1-800-FDA-1088.

How Supplied

Vexasyn wound gel is supplied as a gel in:
1 oz. (28.33g) tube, NDC: 69336-831-01

SPL UNCLASSIFIED SECTION

Distributed By:
Sterling-Knight Pharmaceuticals, LLC
Ripley, MS 38663

Rev 121517-1

Principal Display Panel

INGREDIENTS AND APPEARANCE

VEXASYN 
dressing, wound and burn, hydrogel w/drug and/or biologic

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NHRIC:69336-831

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A)
SODIUM ALGINATE (UNII: C269C4G2ZQ)
GLYCERIN (UNII: PDC6A3C0OX)
HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%) (UNII: R33S7TK2EP)
TROLAMINE (UNII: 9O3K93S3TK)
BENZETHONIUM CHLORIDE (UNII: PH41D05744)
ALOE VERA LEAF (UNII: ZY81Z83H0X)
BOVINE TYPE I COLLAGEN (UNII: FHJ3ATL51C)

Product Characteristics
(SPLSTERILEUSE)	false
(SPLMRISAFE)	true

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NHRIC:69336-831-01	28.33 g in 1 BOTTLE; Type 0: Not a Combination Product	01/02/2018

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
premarket notification	K020540	01/01/2017

Labeler - Sterling-Knight Pharmaceuticals, LLC (079556942)

Establishment
Name	Address	ID/FEI	Business Operations
Sterling-Knight Pharmaceuticals, LLC		079556942	label(69336-831) , analysis(69336-831)